Pharma Execs Buy Calls On Own Brand
The ceo, cfo and two other executives of Swedish pharmaceutical company Meda have acquired 600,000 call options from the company’s majority shareholder Stena Sessan.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
